PharmiWeb2h
One year after its inclusion on WHO’s list of Neglected Tropical Diseases – what should be done next to eliminate noma?
A year after noma was included on the World Health Organization’s (WHO) Neglected Tropical Disease (NTDs) list, Médecins Sans Frontières (MSF) continues its work to encourage early detection and ...
PharmiWeb2h
CellProthera Signs MOU with Shonan Kamakura General Hospital for Use of StemXpand® in Japanese Stem Cell Clinical Trial
CellProthera, a regenerative cell therapy developer specializing in ischemic diseases, announced a new memorandum of understanding with Shonan Kamakura General Hospital (SKGH) to transfer technology ...
PharmiWeb3h
The Impact of AI on Pharmaceutical Quality Assurance
Especially in recent years, Artificial Intelligence (AI) has emerged as a transformative force across industries, and the ...
PharmiWeb4h
AEVIS VICTORIA SA – AEVIS VICTORIA announces the a…
CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 LR Fribourg, 12 December ...
PharmiWeb5h
Eat, drink and be merry! A traditional Christmas feast can help lower LDL ‘bad’ cholesterol.
Fed up hearing dire warnings about cholesterol and alcohol over Christmas? Finally, a leading testing expert says there’s ...
PharmiWeb5h
Everest Medicines: Accelerating Innovation in Renal Disease to Forge a Path Toward Biopharma Leadership
As reported by the South China Morning Post today, Everest Medicines (HKEX 1952.HK) is accelerating its journey to become a leading biopharmaceutical company in the Asia-Pacific region, driven by ...
PharmiWeb5h
Calls for global policy changes to address primary health services that are failing to meet men’s needs
Policymakers are being urged to give greater prominence to men’s use of primary healthcare as a new report shows a severe lack of focus on men’s health needs. Global Action on Men’s Health (GAMH) ...
PharmiWeb5h
Santhera Announces Approval from China’s NMPA for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy
Santhera Pharmaceuticals (SIX: SANN) announces that China’s National Medical Products Administration (NMPA) has approved AGAMREE® (vamorolone) for use in China in patients aged 4 years and older. "DMD ...
PharmiWeb5h
Allegro’s osteoarthritis injectable shock absorbing gel demonstrates preclinical safety
Allegro NV, a biomedical company developing transformative nanotechnology-based devices for degenerative joint disease, today announced that its injectable microparticle gel, hydrocelin, has ...
PharmiWeb5h
ProQR Therapeutics Announces $8.1 Million in New Funding from Rett Syndrome Research Trust to Expand RNA Editing Collaboration
ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today ...
PharmiWeb5h
HONEYWELL’S PHOENIX CONTROLS INTRODUCES NEW PLATFORM FOR SAFER, MORE EFFICIENT OPERATIONS IN CRITICAL ENVIRONMENTS
Phoenix Controls, a Honeywell (NASDAQ: HON) business that provides precision airflow control solutions for critical environments, announced today the launch of the Critical Spaces Control Platform.
PharmiWeb5h
electronRx to Launch purpleDx Pulmonary Disease Smartphone App for Remote Lung Function Monitoring
Rx, a leading digital medicine and biomarker company driving healthcare through pulmonary innovation, today announced that it will launch purpleDx, a cardiopulmonary assessment app built to medical ...